In Vitro and In Vivo Assessments of Newly Isolated N4-like Bacteriophage against ST45 K62 Capsular-Type Carbapenem-Resistant : vB_kpnP_KPYAP-1.

The rise of carbapenem-resistant (CRKP) presents a significant global challenge in clinical and healthcare settings, severely limiting treatment options. This study aimed to utilize a bacteriophage as an alternative therapy against carbapenem-resistant . A novel lytic N4-like phage, vB_kpnP_KPYAP-1 (KPYAP-1), was isolated from sewage.